• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Phenylpyrazoles

Introduction to 5-(3,4-dimethylphenyl)-1H-pyrazole-4-carboxylic Acid (CAS No. 879996-76-6)

5-(3,4-dimethylphenyl)-1H-pyrazole-4-carboxylic acid, with the chemical identifier CAS No. 879996-76-6, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic organic compound has garnered attention due to its versatile structural framework and potential applications in drug discovery and material science. The molecular structure, featuring a pyrazole core substituted with a 3,4-dimethylphenyl group and a carboxylic acid moiety, provides a rich scaffold for further functionalization and derivatization, making it a valuable intermediate in synthetic chemistry.

The< strong>pyrazole ring is a six-membered aromatic heterocycle containing two nitrogen atoms at positions 1 and 5. This configuration imparts unique electronic and steric properties to the molecule, influencing its reactivity and interaction with biological targets. The presence of the< strong>3,4-dimethylphenyl substituent at the 5-position of the pyrazole ring introduces additional steric hindrance and electronic effects, which can modulate the compound's pharmacokinetic and pharmacodynamic profiles. The carboxylic acid group at the 4-position offers further opportunities for chemical modification, such as esterification or amidation, expanding its utility in medicinal chemistry.

In recent years, there has been a growing interest in< strong>pyrazole derivatives due to their broad spectrum of biological activities. These compounds have been explored for their potential as antimicrobial, anti-inflammatory, anticancer, and antiviral agents. The< strong>3,4-dimethylphenyl-substituted pyrazole analogs have shown particular promise in preclinical studies, where they exhibit inhibitory activity against various enzymes and receptors involved in disease pathways. For instance, derivatives of this class have demonstrated efficacy in targeting Janus kinases (JAKs), which are implicated in autoimmune disorders and inflammation.

The< strong>CAS No. 879996-76-6 compound itself has been investigated for its role as a key intermediate in synthesizing more complex pharmacophores. Researchers have leveraged its structural features to develop novel inhibitors of enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are central to the inflammatory response. Additionally, the< strong>pyrazole core has been integrated into peptidomimetics designed to mimic bioactive peptides while offering improved stability and bioavailability. These efforts highlight the compound's significance in the development of next-generation therapeutics.

The synthesis of< strong>5-(3,4-dimethylphenyl)-1H-pyrazole-4-carboxylic acid typically involves multi-step organic transformations starting from readily available precursors. Common synthetic routes include condensation reactions between hydrazine derivatives and β-ketoesters or β-ketoamides, followed by functional group modifications to introduce the desired substituents. Advances in catalytic methods have also enabled more efficient and sustainable synthetic pathways, reducing waste and improving yields. These developments align with the broader trend toward green chemistry principles in pharmaceutical manufacturing.

In terms of applications beyond drug discovery, this compound has found utility in materials science. The< strong>3,4-dimethylphenyl-substituted pyrazole moiety can contribute to the development of novel organic semiconductors and ligands for metal-organic frameworks (MOFs). Its ability to form stable complexes with transition metals makes it a candidate for catalytic applications and luminescent materials. Such interdisciplinary uses underscore the versatility of< strong>CAS No. 879996-76-6 and its derivatives.

The pharmacological profile of< strong>5-(3,4-dimethylphenyl)-1H-pyrazole-4-carboxylic acid has been further explored through computational modeling and high-throughput screening assays. These studies have provided insights into its binding interactions with target proteins and potential side effects. The< strong>pyrazole core's ability to engage with hydrogen bond networks and hydrophobic pockets in macromolecular targets makes it an attractive scaffold for rational drug design. By fine-tuning substituents such as the< strong>3,4-dimethylphenyl group, chemists can optimize potency and selectivity.

Emerging research also suggests that this compound may have applications in agrochemicals. Pyrazole derivatives have been reported to exhibit herbicidal and fungicidal properties due to their interference with essential enzymatic pathways in plants and fungi. The structural features of< strong>CAS No. 879996-76-6, particularly the presence of both aromatic rings and polar functional groups, contribute to its bioactivity against pathogenic organisms while maintaining environmental safety profiles.

In conclusion,< strong>5-(3,4-dimethylphenyl)-1H-pyrazole-4-carboxylic acid (CAS No. 879996-76-6) represents a valuable building block in pharmaceutical chemistry with diverse applications ranging from drug development to materials science. Its unique structural attributes enable extensive chemical modifications, making it instrumental in designing novel therapeutics targeting various diseases. As research continues to uncover new biological functions and synthetic methodologies for this class of compounds, their significance is expected to grow further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)